Inverse benefits due to drug marketing undermine patient safety and public health, study finds
Sunday, January 16, 2011 - 14:30
in Health & Medicine
Drugs that pharmaceutical companies market most aggressively to physicians and patients tend to offer less benefit and more harm to most patients -- a phenomenon described as the "inverse benefit law," according to new research.